Telix Pharmaceuticals TLX
NASDAQ TLX
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Accounts Payables (2023 - 2026)

Updated

Telix Pharmaceuticals' Accounts Payables was $168.97 million in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Accounts Payables (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Accounts Payables at Telix Pharmaceuticals came in at $150.35 million, up 73.2% from the prior year.

  • In earlier years, Accounts Payables was $86.79 million in the year ended Dec 31, 2024 (+59.7%) and $54.33 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 Telix Pharmaceuticals 3.84 Bn 2.78 Bn - 168.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168.97 Mn
Dec 31, 2025 150.35 Mn
Dec 31, 2024 91.51 Mn
Dec 31, 2023 53.19 Mn
API Access

Telix Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=TLX&period=max&api_key=YOUR_API_KEY